125 related articles for article (PubMed ID: 36482232)
41. Thyroid cancer risk in women after hysterectomy: A nationwide cohort study.
Tai TS; Tsai CF; Yang HY
Maturitas; 2024 Jul; 185():107980. PubMed ID: 38555761
[TBL] [Abstract][Full Text] [Related]
42. Long-term overall and disease-specific mortality associated with benign gynecologic surgery performed at different ages.
Gierach GL; Pfeiffer RM; Patel DA; Black A; Schairer C; Gill A; Brinton LA; Sherman ME
Menopause; 2014 Jun; 21(6):592-601. PubMed ID: 24253486
[TBL] [Abstract][Full Text] [Related]
43. Attitudes of Israeli gynecologists towards risk reduction salpingo-oophorectomy at hysterectomy for benign conditions and the use of hormonal therapy.
Assaf W; Andraous M; Lavie O; Segev Y
Eur J Obstet Gynecol Reprod Biol; 2022 May; 272():48-54. PubMed ID: 35279641
[TBL] [Abstract][Full Text] [Related]
44. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
45. Management Strategies for the Ovaries at the Time of Hysterectomy for Benign Disease.
Matthews CA
Obstet Gynecol Clin North Am; 2016 Sep; 43(3):539-49. PubMed ID: 27521883
[TBL] [Abstract][Full Text] [Related]
46. Factors affecting gynaecologists' decision to perform prophylactic oophorectomy concomitantly with hysterectomy: a Belgian survey.
Plusquin C; Fastrez M; Vandromme J; Rozenberg S
Maturitas; 2011 Dec; 70(4):391-4. PubMed ID: 22014472
[TBL] [Abstract][Full Text] [Related]
47. Postdiagnosis alcohol consumption and breast cancer prognosis in the after breast cancer pooling project.
Kwan ML; Chen WY; Flatt SW; Weltzien EK; Nechuta SJ; Poole EM; Holmes MD; Patterson RE; Shu XO; Pierce JP; Caan BJ
Cancer Epidemiol Biomarkers Prev; 2013 Jan; 22(1):32-41. PubMed ID: 23150063
[TBL] [Abstract][Full Text] [Related]
48. Removal of all ovarian tissue versus conserving ovarian tissue at time of hysterectomy in premenopausal patients with benign disease: study using routine data and data linkage.
Mytton J; Evison F; Chilton PJ; Lilford RJ
BMJ; 2017 Feb; 356():j372. PubMed ID: 28167486
[TBL] [Abstract][Full Text] [Related]
49. Long-term mortality associated with oophorectomy compared with ovarian conservation in the nurses' health study.
Parker WH; Feskanich D; Broder MS; Chang E; Shoupe D; Farquhar CM; Berek JS; Manson JE
Obstet Gynecol; 2013 Apr; 121(4):709-716. PubMed ID: 23635669
[TBL] [Abstract][Full Text] [Related]
50. Hysterectomy and Bilateral Salpingo-Oophorectomy: Variations by History of Military Service and Birth Cohort.
Callegari LS; Gray KE; Zephyrin LC; Harrington LB; Gerber MR; Cochrane BB; Weitlauf JC; Bean-Mayberry B; Bastian LA; Mattocks KM; Haskell SG; Katon JG
Gerontologist; 2016 Feb; 56 Suppl 1(Suppl 1):S67-77. PubMed ID: 26768393
[TBL] [Abstract][Full Text] [Related]
51. Association of bilateral salpingo-oophorectomy with all cause and cause specific mortality: population based cohort study.
Cusimano MC; Chiu M; Ferguson SE; Moineddin R; Aktar S; Liu N; Baxter NN
BMJ; 2021 Dec; 375():e067528. PubMed ID: 34880044
[TBL] [Abstract][Full Text] [Related]
52. Removal of normal ovaries in women under age 51 at the time of hysterectomy.
Karp NE; Fenner DE; Burgunder-Zdravkovski L; Morgan DM
Am J Obstet Gynecol; 2015 Nov; 213(5):716.e1-6. PubMed ID: 26032038
[TBL] [Abstract][Full Text] [Related]
53. Effects of bilateral salpingo-oophorectomy at the time of hysterectomy on pelvic organ prolapse: results from the Women's Health Initiative trial.
Shveiky D; Kudish BI; Iglesia CB; Park AJ; Sokol AI; Lehman AM; Shara N; Howard BV
Menopause; 2015 May; 22(5):483-8. PubMed ID: 25423323
[TBL] [Abstract][Full Text] [Related]
54. Determinants of the decision to perform prophylactic oophorectomy in association with a hysterectomy for a benign condition.
Plusquin C; Fastrez M; Vandromme J; Rozenberg S
Maturitas; 2012 Oct; 73(2):164-6. PubMed ID: 22964073
[TBL] [Abstract][Full Text] [Related]
55. Hormone Replacement Therapy After Oophorectomy and Breast Cancer Risk Among BRCA1 Mutation Carriers.
Kotsopoulos J; Gronwald J; Karlan BY; Huzarski T; Tung N; Moller P; Armel S; Lynch HT; Senter L; Eisen A; Singer CF; Foulkes WD; Jacobson MR; Sun P; Lubinski J; Narod SA;
JAMA Oncol; 2018 Aug; 4(8):1059-1065. PubMed ID: 29710224
[TBL] [Abstract][Full Text] [Related]
56. Postoophorectomy estrogen use and breast cancer risk.
Nichols HB; Trentham-Dietz A; Newcomb PA; Titus LJ; Egan KM; Hampton JM; Visvanathan K
Obstet Gynecol; 2012 Jul; 120(1):27-36. PubMed ID: 22914389
[TBL] [Abstract][Full Text] [Related]
57. Incidence of ovarian cancer after bilateral salpingo-oophorectomy in women with histologically proven endometriosis.
Hermens M; van Altena AM; Bulten J; van Vliet HAAM; Siebers AG; Bekkers RLM
Fertil Steril; 2022 May; 117(5):938-945. PubMed ID: 35300832
[TBL] [Abstract][Full Text] [Related]
58. Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.
Domchek SM; Friebel TM; Singer CF; Evans DG; Lynch HT; Isaacs C; Garber JE; Neuhausen SL; Matloff E; Eeles R; Pichert G; Van t'veer L; Tung N; Weitzel JN; Couch FJ; Rubinstein WS; Ganz PA; Daly MB; Olopade OI; Tomlinson G; Schildkraut J; Blum JL; Rebbeck TR
JAMA; 2010 Sep; 304(9):967-75. PubMed ID: 20810374
[TBL] [Abstract][Full Text] [Related]
59. Subsequent Oophorectomy and Ovarian Cancer after Hysterectomy for Benign Gynecologic Conditions at Chiang Mai University Hospital.
Jitkunnatumkul A; Tantipalakorn C; Charoenkwan K; Srisomboon J
Asian Pac J Cancer Prev; 2016; 17(8):3845-8. PubMed ID: 27644627
[TBL] [Abstract][Full Text] [Related]
60. Practice variation in bilateral salpingo-oophorectomy at benign abdominal hysterectomy: a population-based study.
Cusimano MC; Moineddin R; Chiu M; Ferguson SE; Aktar S; Liu N; Baxter NN
Am J Obstet Gynecol; 2021 Jun; 224(6):585.e1-585.e30. PubMed ID: 33359174
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
